Snowball logo
logo
DRUG

Bright Minds Biosciences Inc

DRUG NASDAQ
$83.55-$2.36  (2.75%)

Frequently asked questions

What sector does Bright Minds Biosciences Inc (DRUG) operate in?

Bright Minds Biosciences Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Bright Minds Biosciences Inc (DRUG) current stock price?

As of the latest data, Bright Minds Biosciences Inc stock price is $83.55, with a previous close of $85.91. Bright Minds Biosciences Inc lost -$2.36 in the last trading session, representing a -2.75% loss.

What is Bright Minds Biosciences Inc (DRUG) current market capitalization?

Bright Minds Biosciences Inc market cap is approximately 817.72 million.

What is Bright Minds Biosciences Inc (DRUG) Earnings Per Share (EPS)?

The trailing EPS is -$2.01, and the forward EPS is -$9.07.

What is Bright Minds Biosciences Inc (DRUG) EBITDA?

Bright Minds Biosciences Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -5.02 million.

Does Bright Minds Biosciences Inc (DRUG) pay dividends?

No. Bright Minds Biosciences Inc does not pay a dividend.

What is Bright Minds Biosciences Inc (DRUG) beta (volatility) score?

Bright Minds Biosciences Inc has a beta of -0.752, indicating lower volatility than the overall market.